1 Market Overview of Anti Neurofilament L Antibody 1.1 Anti Neurofilament L Antibody Market Overview 1.1.1 Anti Neurofilament L Antibody Product Scope 1.1.2 Market Status and Outlook 1.2 Global Anti Neurofilament L Antibody Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Anti Neurofilament L Antibody Market Size by Region (2015-2026) 1.4 Global Anti Neurofilament L Antibody Historic Market Size by Region (2015-2020) 1.5 Global Anti Neurofilament L Antibody Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.1 North America Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.2 Europe Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.3 China Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.4 Rest of Asia Pacific Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.5 Latin America Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 1.6.6 Middle East & Africa Anti Neurofilament L Antibody Market Size YoY Growth (2015-2026) 2 Anti Neurofilament L Antibody Market Overview by Type 2.1 Global Anti Neurofilament L Antibody Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Anti Neurofilament L Antibody Historic Market Size by Type (2015-2020) 2.3 Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2021-2026) 2.4 Mouse Anti Neurofilament L Antibody 2.5 Rabbit Anti Neurofilament L Antibody 2.6 Others 3 Anti Neurofilament L Antibody Market Overview by Application 3.1 Global Anti Neurofilament L Antibody Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Anti Neurofilament L Antibody Historic Market Size by Application (2015-2020) 3.3 Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2021-2026) 3.4 Academic and Research Institutes 3.5 Pharma and Biotech Companies 3.6 Others 4 Global Anti Neurofilament L Antibody Competition Analysis by Players 4.1 Global Anti Neurofilament L Antibody Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Neurofilament L Antibody as of 2019) 4.3 Date of Key Manufacturers Enter into Anti Neurofilament L Antibody Market 4.4 Global Top Players Anti Neurofilament L Antibody Headquarters and Area Served 4.5 Key Players Anti Neurofilament L Antibody Product Solution and Service 4.6 Competitive Status 4.6.1 Anti Neurofilament L Antibody Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Merck 5.1.1 Merck Profile 5.1.2 Merck Main Business and Company’s Total Revenue 5.1.3 Merck Products, Services and Solutions 5.1.4 Merck Revenue (US$ Million) (2015-2020) 5.1.5 Merck Recent Development and Reaction to Covid-19 5.2 BioLegend 5.2.1 BioLegend Profile 5.2.2 BioLegend Main Business and Company’s Total Revenue 5.2.3 BioLegend Products, Services and Solutions 5.2.4 BioLegend Revenue (US$ Million) (2015-2020) 5.2.5 BioLegend Recent Development and Reaction to Covid-19 5.3 Cell Signaling Technology 5.5.1 Cell Signaling Technology Profile 5.3.2 Cell Signaling Technology Main Business and Company’s Total Revenue 5.3.3 Cell Signaling Technology Products, Services and Solutions 5.3.4 Cell Signaling Technology Revenue (US$ Million) (2015-2020) 5.3.5 Rockland Immunochemicals Recent Development and Reaction to Covid-19 5.4 Rockland Immunochemicals 5.4.1 Rockland Immunochemicals Profile 5.4.2 Rockland Immunochemicals Main Business and Company’s Total Revenue 5.4.3 Rockland Immunochemicals Products, Services and Solutions 5.4.4 Rockland Immunochemicals Revenue (US$ Million) (2015-2020) 5.4.5 Rockland Immunochemicals Recent Development and Reaction to Covid-19 5.5 Bio-Rad Laboratories 5.5.1 Bio-Rad Laboratories Profile 5.5.2 Bio-Rad Laboratories Main Business and Company’s Total Revenue 5.5.3 Bio-Rad Laboratories Products, Services and Solutions 5.5.4 Bio-Rad Laboratories Revenue (US$ Million) (2015-2020) 5.5.5 Bio-Rad Laboratories Recent Development and Reaction to Covid-19 5.6 EnCor Biotechnology 5.6.1 EnCor Biotechnology Profile 5.6.2 EnCor Biotechnology Main Business and Company’s Total Revenue 5.6.3 EnCor Biotechnology Products, Services and Solutions 5.6.4 EnCor Biotechnology Revenue (US$ Million) (2015-2020) 5.6.5 EnCor Biotechnology Recent Development and Reaction to Covid-19 ... 6 North America Anti Neurofilament L Antibody by Players and by Application 6.1 North America Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 6.2 North America Anti Neurofilament L Antibody Market Size by Application (2015-2020) 7 Europe Anti Neurofilament L Antibody by Players and by Application 7.1 Europe Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 7.2 Europe Anti Neurofilament L Antibody Market Size by Application (2015-2020) 8 China Anti Neurofilament L Antibody by Players and by Application 8.1 China Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 8.2 China Anti Neurofilament L Antibody Market Size by Application (2015-2020) 9 Rest of Asia Pacific Anti Neurofilament L Antibody by Players and by Application 9.1 Rest of Asia Pacific Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 9.2 Rest of Asia Pacific Anti Neurofilament L Antibody Market Size by Application (2015-2020) 10 Latin America Anti Neurofilament L Antibody by Players and by Application 10.1 Latin America Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 10.2 Latin America Anti Neurofilament L Antibody Market Size by Application (2015-2020) 11 Middle East & Africa Anti Neurofilament L Antibody by Players and by Application 11.1 Middle East & Africa Anti Neurofilament L Antibody Market Size and Market Share by Players (2015-2020) 11.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2015-2020) 12 Anti Neurofilament L Antibody Market Dynamics 12.1 Covid-19 Impact: Industry Trends 12.2 Covid-19 Impact: Market Drivers 12.3 Covid-19 Impact: Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables Table 1. Global Market Anti Neurofilament L Antibody Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Anti Neurofilament L Antibody Market Size by Region (2015-2020) (US$ Million) Table 3. Global Anti Neurofilament L Antibody Market Size Share by Region (2015-2020) Table 4. Global Anti Neurofilament L Antibody Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Anti Neurofilament L Antibody Forecasted Market Size Share by Region (2021-2026) Table 6. Global Anti Neurofilament L Antibody Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Anti Neurofilament L Antibody Market Size by Type (2015-2020) (US$ Million) Table 8. Global Anti Neurofilament L Antibody Revenue Market Share by Type (2015-2020) Table 9. Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Anti Neurofilament L Antibody Revenue Market Share by Type (2021-2026) Table 11. Global Anti Neurofilament L Antibody Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 13. Global Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Table 14. Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Anti Neurofilament L Antibody Revenue Market Share by Application (2021-2026) Table 16. Global Anti Neurofilament L Antibody Revenue (US$ Million) by Players (2015-2020) Table 17. Global Anti Neurofilament L Antibody Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Neurofilament L Antibody as of 2019) Table 19. Date of Key Manufacturers Enter into Anti Neurofilament L Antibody Market Table 20. Global Anti Neurofilament L Antibody Top Players Headquarters and Area Served Table 21. Anti Neurofilament L Antibody Product Solution and Service Table 22. Global Anti Neurofilament L Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Merck Basic Information List Table 25. Merck Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 26. Merck Anti Neurofilament L Antibody Products, Services and Solutions Table 27. Revenue (Million US$) in Anti Neurofilament L Antibody Business of Merck (2015-2020) Table 28. Merck Recent Developments Table 29. BioLegend Basic Information List Table 30. BioLegend Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 31. BioLegend Anti Neurofilament L Antibody Products, Services and Solutions Table 32. Revenue (Million US$) in Anti Neurofilament L Antibody Business of BioLegend (2015-2020) Table 33. BioLegend Recent Developments Table 34. Cell Signaling Technology Basic Information List Table 35. Cell Signaling Technology Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 36. Cell Signaling Technology Anti Neurofilament L Antibody Products, Services and Solutions Table 37. Revenue (Million US$) in Anti Neurofilament L Antibody Business of Cell Signaling Technology (2015-2020) Table 38. Cell Signaling Technology Recent Developments Table 39. Rockland Immunochemicals Basic Information List Table 40. Rockland Immunochemicals Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 41. Rockland Immunochemicals Anti Neurofilament L Antibody Products, Services and Solutions Table 42. Revenue (Million US$) in Anti Neurofilament L Antibody Business of Rockland Immunochemicals (2015-2020) Table 43. Rockland Immunochemicals Recent Developments Table 44. Bio-Rad Laboratories Basic Information List Table 45. Bio-Rad Laboratories Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 46. Bio-Rad Laboratories Anti Neurofilament L Antibody Products, Services and Solutions Table 47. Revenue (Million US$) in Anti Neurofilament L Antibody Business of Bio-Rad Laboratories (2015-2020) Table 48. Bio-Rad Laboratories Recent Developments Table 49. EnCor Biotechnology Basic Information List Table 50. EnCor Biotechnology Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 51. EnCor Biotechnology Anti Neurofilament L Antibody Products, Services and Solutions Table 52. Revenue (Million US$) in Anti Neurofilament L Antibody Business of EnCor Biotechnology (2015-2020) Table 53. EnCor Biotechnology Recent Developments Table 54. Global Anti Neurofilament L Antibody Market Size by Type (2015-2020) (Million US$) Table 55. North America Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 56. North America Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) Table 57. North America Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 58. Europe Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 59. Europe Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) Table 60. Europe Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 61. China Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 62. China Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) (US$ Million) Table 63. China Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 64. Rest of Asia Pacific Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 65. Rest of Asia Pacific Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) (US$ Million) Table 66. Rest of Asia Pacific Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 67. Latin America Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 68. Latin America Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) (US$ Million) Table 69. Latin America Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 70. Middle East & Africa Anti Neurofilament L Antibody Market Size by Players (2015-2020) (US$ Million) Table 71. Middle East & Africa Anti Neurofilament L Antibody Market Size Share by Players (2015-2020) (US$ Million) Table 72. Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2015-2020) (US$ Million) Table 73. Market Top Trends Table 74. Key Drivers: Impact Analysis (2021-2026) Table 75. Key Challenges Table 76. Research Programs/Design for This Report Table 77. Key Data Information from Secondary Sources Table 78. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti Neurofilament L Antibody Market Size (US$ Million) Status and Outlook (2015-2026) Figure 2. Global Anti Neurofilament L Antibody Market Share by Regions: 2020 VS 2026 Figure 3. North America Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 4. Europe Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 5. China Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Rest of Asia Pacific Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Anti Neurofilament L Antibody Market Share by Type in 2020 & 2026 Figure 10. Mouse Anti Neurofilament L Antibody Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Rabbit Anti Neurofilament L Antibody Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Anti Neurofilament L Antibody Market Size Share by Application in 2020 & 2026 Figure 14. Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate in Academic and Research Institutes (2015-2020) Figure 15. Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate in Pharma and Biotech Companies (2015-2020) Figure 16. Anti Neurofilament L Antibody Market Size (US$ Million) and Growth Rate in Others (2015-2020) Figure 17. Anti Neurofilament L Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Anti Neurofilament L Antibody Market Share in 2019 Figure 19. Europe Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Figure 20. China Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Figure 21. Rest of Asia Pacific Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Figure 22. Latin America Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Figure 23. Middle East & Africa Anti Neurofilament L Antibody Revenue Market Share by Application (2015-2020) Figure 24. Porter's Five Forces Analysis Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation

Merck BioLegend Cell Signaling Technology Rockland Immunochemicals Bio-Rad Laboratories EnCor Biotechnology